Literature DB >> 33523503

Hepatitis B virus reactivation in cancer patients receiving direct-acting antivirals for hepatitis C virus infection.

Haley Pritchard1,2,3, Jessica P Hwang4, Georgios Angelidakis2, Marcel Yibirin2, Lan Wang5, Ethan Miller5, Harrys A Torres2,5.   

Abstract

Entities:  

Keywords:  cancer; direct-acting antivirals; hepatitis B virus; hepatitis C virus; hepatitis flare; hepatology; liver enzymes; liver failure; prophylaxis; reactivation

Mesh：

Substances：

Year:  2021        PMID： 33523503      PMCID： PMC8928572          DOI： 10.1111/jvh.13478

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN： 1352-0504            Impact factor:   3.728


× No keyword cloud information.
  14 in total

Review 1.  Reactivation of hepatitis B virus and hepatitis C virus in patients with cancer.

Authors:  Harrys A Torres; Marta Davila
Journal:  Nat Rev Clin Oncol       Date:  2012-01-24       Impact factor: 66.675

Review 2.  Management of patients with hepatitis B who require immunosuppressive therapy.

Authors:  Jessica P Hwang; Anna S-F Lok
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-11-19       Impact factor: 46.802

3.  Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.

Authors:  Norah A Terrault; Anna S F Lok; Brian J McMahon; Kyong-Mi Chang; Jessica P Hwang; Maureen M Jonas; Robert S Brown; Natalie H Bzowej; John B Wong
Journal:  Hepatology       Date:  2018-04       Impact factor: 17.425

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

5.  Hepatitis C Virus Infection in Patients With Cancer: Impact on Clinical Trial Enrollment, Selection of Therapy, and Prognosis.

Authors:  Harrys A Torres; Pooja Pundhir; Vincent Mallet
Journal:  Gastroenterology       Date:  2019-02-21       Impact factor: 22.682

6.  HBV reactivation during direct-acting antiviral therapy in hepatitis B and C coinfected patients undergoing haemodialysis.

Authors:  Jing Wang; Chunhua Hu; Yi Chen; Zhengwen Liu; Qiang Yu; Shujuan Yang; Jun Dong; Yuan Yang; Yuchao Wu; Danfeng Ren; Naijuan Yao; Dandan Guo; Zhen Tian; Yingren Zhao; Tianyan Chen; Yingli He; Jinfeng Liu
Journal:  Antivir Ther       Date:  2019

7.  Sofosbuvir-Based Therapy in Hepatitis C Virus-Infected Cancer Patients: A Prospective Observational Study.

Authors:  Harrys A Torres; Minas P Economides; Georgios Angelidakis; Jeff Hosry; Andreas Kyvernitakis; Parag Mahale; Ying Jiang; Ethan Miller; Boris Blechacz; Aung Naing; Felipe Samaniego; Ahmed Kaseb; Issam I Raad; Bruno P Granwehr
Journal:  Am J Gastroenterol       Date:  2019-02       Impact factor: 10.864

Review 8.  Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.

Authors:  Marcus M Mücke; Lisa I Backus; Victoria T Mücke; Nicola Coppola; Carmen M Preda; Ming-Lun Yeh; Lydia S Y Tang; Pamela S Belperio; Eleanor M Wilson; Ming-Lung Yu; Stefan Zeuzem; Eva Herrmann; Johannes Vermehren
Journal:  Lancet Gastroenterol Hepatol       Date:  2018-01-19

9.  Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.

Authors:  Jessica P Hwang; Mark R Somerfield; Devena E Alston-Johnson; Donna R Cryer; Jordan J Feld; Barnett S Kramer; Anita L Sabichi; Sandra L Wong; Andrew S Artz
Journal:  J Clin Oncol       Date:  2015-05-11       Impact factor: 44.544

Review 10.  Prophylaxis of hepatitis B virus (HBV) infection reactivation - recommendations of the Working Group for prevention of HBV reactivation.

Authors:  Małgorzata Pawłowska; Robert Flisiak; Lidia Gil; Andrzej Horban; Iwona Hus; Jerzy Jaroszewicz; Ewa Lech-Marańda; Jan Styczyński
Journal:  Clin Exp Hepatol       Date:  2019-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.